France Laudat

Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine in HIV-infected individuals naive to pneumococcal vaccination

As’ad E. Bhorat, Shabir A. Madhi, France Laudat et al. · AIDS · 2015 · 55 citations · Full text

Safety and immunogenicity of CRM197-conjugated pneumococcal–meningococcal C combination vaccine (9vPnC–MnCC) whether given in two or three primary doses

Sigurveig Sigurdardottir, Katrín Davíðsdóttir, Vilhjalmur A. Arason et al. · Vaccine · 2008 · 37 citations

Vaccination, Vaccine Safety, Vaccine Development +7

Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine (PCV13) when given as a toddler dose to children immunized with PCV7 as infants

E. Grimprel, France Laudat, Scott D. Patterson et al. · Vaccine · 2011 · 32 citations

Vaccinology, Vaccine Safety, Vaccination +9

A clinical trial examining the effect of increased total CRM197 carrier protein dose on the antibody response to Haemophilus influenzae type b CRM197 conjugate vaccine

Vytautas Usonis, V. Bakasénas, Stephen Lockhart et al. · Vaccine · 2008 · 15 citations

Vaccination, Vaccine Development, Immunology +5

Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine (PCV13) formulated with 2-phenoxyethanol in multidose vials given with routine vaccination in healthy infants: An open-label randomized controlled trial

Olubukola T. Idoko, Robert Mboizi, Michael Okoye et al. · Vaccine · 2017 · 13 citations · Full text

Vaccinology, Vaccination, Vaccine Safety +9